Sign up to save your podcasts
Or
Share Jefferies London: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and walks us through a few of his firm's top positions
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Jefferies London: Affinity Asset Advisors' Patrick Nosker shares a public investor's perspective on biotech and walks us through a few of his firm's top positions
He describes getting through the last few years and how he thinks about 2026. Plus, comments on Xenon, Madrigal, and Alkermes.
View all episodes
By BiotechTV
4.3
66 ratings
He describes getting through the last few years and how he thinks about 2026. Plus, comments on Xenon, Madrigal, and Alkermes.
More shows like BiotechTV - News
View all
We Study Billionaires - The Investor’s Podcast Network
3,372 Listeners
Bloomberg Businessweek
418 Listeners
WSJ Tech News Briefing
1,645 Listeners
The Meb Faber Show - Better Investing
946 Listeners
The Long Run with Luke Timmerman
123 Listeners
The Readout Loud
321 Listeners
Value Investing with Legends
211 Listeners
Fiction - Comedy Fiction
6,443 Listeners
Biotech 2050 Podcast
62 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
10,024 Listeners
Business Of Biotech
86 Listeners
BioCentury This Week
34 Listeners
Biotech Hangout
20 Listeners
The Studio at Kendall Square
0 Listeners
Off-Target Effects with Matt Gline
4 Listeners
Biotech CEO Sisterhood
2 Listeners
BioVenture VoiCes with Chris Garabedian
5 Listeners
Cheeky Pint
37 Listeners